Covista Inc(CVSA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 19.3 | EPS (ttm) | 6.55 | Insider Own | 2.89% | Shs Outstand | 34.0M | Perf Week | -0.33% |
| Market Cap | 4.28B | Forward P/E | 12.64 | EPS next Y | 10.61% | Insider Trans | -7.46% | Shs Float | 32.9M | Perf Month | 5.9% |
| Enterprise Value | 4.77B | PEG | 1.21 | EPS next Q | 1.83 | Inst Own | 102.99% | Short Float | 8.45% | Perf Quarter | 0.05% |
| Income | 0.27B | P/S | 2.19 | EPS this Y | 9.64% | Inst Trans | -0.53% | Short Ratio | 8.28 | Perf Half Y | 10.36% |
| Sales | 1.95B | P/B | 2.98 | EPS next 5Y | 10.43% | ROA | 9.09% | Short Interest | 2.78M | Perf YTD | 22.26% |
| Book/sh | 42.49 | P/C | 10.12 | EPS past 3/5Y | 52.14% 38.12% | ROE | 18.57% | 52W High | -18.34% ($154.90) | Perf Year | -17.85% |
| Cash/sh | 12.5 | P/FCF | 10.91 | Sales past 3/5Y | 10.44% 16.59% | ROIC | 11.57% | 52W Low | 45.45% ($86.97) | Perf 3Y | 153.1% |
| Dividend Est. | - | EV/EBITDA | 10.08 | EPS Y/Y TTM | 19.32% | Gross Margin | 60.28% | Volatility(W/M) | 3.41% 2.81% | Perf 5Y | 232.63% |
| Dividend TTM | - | EV/Sales | 2.44 | Sales Y/Y TTM | 9.27% | Oper. Margin | 19.94% | ATR (14) | 3.85 | Perf 10Y | 447.38% |
| Dividend Ex-Date | 2016/11/30 | Quick Ratio | 1.09 | EPS Q/Q | 43.25% | Profit Margin | 13.68% | RSI (14) | 46.65 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.09 | Sales Q/Q | 9.69% | SMA20 | -1.32% ($128.19) | Beta | 0.7 | Target Price | $158.75 |
| Payout | - | Debt/Eq | 0.63 | Earnings | 2026/10/29 | SMA50 | -1.2% ($128.04) | Rel Volume | 0.97 | Prev Close | $129.26 |
| Employees | 10680 | LT Debt/Eq | 0.6 | EPS/Sales Surpr. | 10.44% 3.04% | SMA200 | 5.82% ($119.54) | Avg Volume(3M) | 0.34M | Price | $126.5 |
| IPO | 1991/6/21 | Option/Short | Yes/Yes | Trades | 5810 | Volume | 326,727 | Change | -2.14% |
🩺 This is a healthcare education company that provides medical training in the U.S. and the Caribbean region. It operates degree and non-degree programs in nursing, medicine, veterinary medicine, and health/psychology, and owns educational institutions such as Chamberlain, Walden, and Ross. The company is a healthcare education provider exposed to the structural demand driven by shortages of medical professionals.
Over the past 1 year, roughly in the middle
18% below its 1-year high.
Traded about as much as usual. That is 97% of its average volume.
Next earnings report: October 29
That is today.
CVSA makes money exceptionally well
Of every $100 in sales, $19.94 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.6% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,008. Peers typically go for $684. It is about in line with its own 5-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +232.6%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 103.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #3 of 43 in the industry
Based on market cap of $4B.
FAQ
What kind of company is CVSA?
CVSA belongs to the Consumer Defensive sector and operates in the Education & Training Services industry.
What is the market cap of CVSA?
The market cap of CVSA is approximately $4.3B, ranking 1,486 within its sector.
What is the P/E ratio of CVSA?
CVSA has a P/E ratio of approximately 19.3x, which can be used to assess its valuation relative to the Consumer Defensive sector average.
What is the 52-week high and low for CVSA?
CVSA has recorded a 52-week high of $154.90 and a low of $86.97.
